Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease

Blood

Volumn 88, Issue 12, 1996, Pages 4429-4434

  Nichols, William C ^b   Antin, Joseph H ^b   Lunetta, Kathryn L ^b   Terry, Valeri H ^b   Hertel, Colette E ^b   Wheatley, Matthew A ^b   Arnold, Nathan D ^b   Siemieniak, David R ^b   Boehnke, Michael ^b   Ginsburg, David ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b 4520 MSRB I ^*

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN;

ARTICLE; BONE MARROW TRANSPLANTATION; DNA POLYMORPHISM; DONOR; GENOTYPE; GRAFT VERSUS HOST REACTION; HISTOINCOMPATIBILITY; HLA MATCHING; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 10544236118     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.12.4429.bloodjournal88124429     Document Type: Article

References (31)

1. Korngold R: Biology of graft-vs.-host disease. Am J Pediatr Hematol Oncol 15:18, 1993
2. Ferrara JL, Deeg HJ: Graft-versus-host disease. N Engl J Med 324:667, 1991
3. Vogelsang GB, Wagner JE: Graft-versus-host disease. Hematol Oncol Clin North Am 4:625, 1990
4. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SY, Petersdorf EW, Pepe MS, Appelbaum FR, Bearman SI, Buckner CD, Clift RA, Petersen FB, Singer J, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP, Thomas ED: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 81:249, 1993
5. Mickelson EM, Anasetti C, Yoon Choo S, Longton GM, Petersdorf EW, Martin PJ, Hansen JA: Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors. Transplant Proc 25:1239, 1993
6. Vogelsang GV: Acute graft-versus-host disease following marrow transplantation, in Sullivan KM, Koppa SD, Thomas ED (eds): Marrow Transplantation Reviews. 1991-1994: Biology and Clinical Practice of Hematopoietic Transplantation. Charlottesville, VA, Kluge Carden Jennings, 1995, p 150
7. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroneck D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
8. Sullivan KM: Graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 339
9. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329:1225, 1993
10. Kernan NA, Dupont B: Minor histocompatibility antigens and marrow transplantation. N Engl J Med 334:323, 1996
11. Korngold R: Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens. Bone Marrow Transplant 7:38, 1991 (suppl 1)
12. Goulmy E, Voogt P, van Els C, de Bueger M, van Rood J: The role of minor histocompatibility antigens in GVHD and rejection: A mini-review. Bone Marrow Transplant 7:49, 1991 (suppl 1)
13. van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ, van Rood JJ, Goulmy E: Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance. Immunogenetics 35:161, 1992
14. Wang W, Meadows LR, den Haan JM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, Hunt DF, Goulmy E, Engelhard VH: Human H-Y: A malespecific histocompatibility antigen derived from the SMCY protein. Science 269:1588, 1995
15. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JHF, Vossen J, Gratwohl A, Vogelsang GB, van Houwelingen HC, van Rood JJ: Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 334:281, 1996
16. den Haan JMM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E: Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268:1476, 1995
17. Behar E, Chao NJ, Hiraki DD, Krishnaswamy S, Brown BW, Zehnder JL, Grumet FC: Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 334:286, 1996
18. Albelda SM, Muller WA, Buck CA, Newman PJ: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 114:1059, 1991
19. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, Muller WA: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219, 1990
20. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
21. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18:295, 1974
22. Thomas E, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
23. Kirschbaum NE, van Tuinen P, Newman PJ: Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84:4028, 1994
24. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF: Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 90:2842, 1993
25. Agresti A: Categorical Data Analysis. New York, NY, John Wiley and Sons, 1990
26. Boehnke M: Allele frequency estimation from data on relatives. Am J Hum Genet 48:22, 1991
27. Schreuder GM, Pool J, Blokland E, van Els C, Bakker A, van Rood JJ, Goulmy E: A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA. Immunogenetics 38:98, 1993
28. Marijt EA, Veenhof WF, Goulmy E, Kluck PM, Brand A, Willemze R, van Rood JJ, Falkenburg JH: Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Hum Immunol 37:221, 1993
29. Dyer PA, Short CD, Clarke EA, Mallick NP: HLA antigen and gene polymorphisms and haplotypes established by family studies in membranous nephropathy. Nephrol Dial Transplant 7:42,1992 (suppl 1)
30. Reed E, Ho E, Lupu F, McManus P, Vasilescu R, FocaRodi A, Suciu-Foca N: Polymorphism of HLA in the Romanian population. Tissue Antigens 39:8, 1992
31. Gumina RJ, Kirschbaum NE, van Tuinen P, Newman PJ: Localization of the human PECAM-1 gene to the long arm of chromosome 17: Relationship to the glyco-protein IIb/IIIa complex and ICAM-2. Thromb Haemost 69:923a, 1993